1 MONTELUKAST SODIUM | 200 of 940 | 1810 prescriptions Less than 1% of all prescriptions | 1650 | 520 patients 19% of all patients | < 11 | |
2 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 140 of 930 | 2030 prescriptions Less than 1% of all prescriptions | 1780 | 560 patients 20% of all patients | < 11 | |
3 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 440 of 1020 | 1050 prescriptions Less than 1% of all prescriptions | | 360 patients 13% of all patients | < 11 | |
4 VENTOLIN HFA (ALBUTEROL SULFATE) | 360 of 1070 | 1360 prescriptions Less than 1% of all prescriptions | 970 | 470 patients 17% of all patients | 360 patients 13% of all patients | |
5 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 430 of 990 | 730 prescriptions Less than 1% of all prescriptions | 400 | 200 patients 7% of all patients | < 11 | |
6 FLUTICASONE PROPIONATE | 160 of 780 | 680 prescriptions Less than 1% of all prescriptions | 570 | 280 patients 10% of all patients | < 11 | |
7 PREDNISONE | 490 of 1100 | 720 prescriptions Less than 1% of all prescriptions | | 300 patients 11% of all patients | < 11 | |
8 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 430 of 910 | 580 prescriptions Less than 1% of all prescriptions | | 150 patients 5% of all patients | < 11 | |
9 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 240 of 740 | 490 prescriptions Less than 1% of all prescriptions | | 180 patients 7% of all patients | < 11 | |
10 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 450 of 930 | 510 prescriptions Less than 1% of all prescriptions | 340 | 140 patients 5% of all patients | < 11 | |
11 OFEV (NINTEDANIB ESYLATE) | 50 of 380 | 620 prescriptions Less than 1% of all prescriptions | 620 | < 11 | < 11 | |
12 SPIRIVA (TIOTROPIUM BROMIDE) | 300 of 820 | 430 prescriptions Less than 1% of all prescriptions | 310 | < 11 | < 11 | |
13 THEOPHYLLINE ANHYDROUS | 90 of 190 | 260 prescriptions Less than 1% of all prescriptions | 260 | < 11 | < 11 | |
14 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 200 of 520 | 330 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
15 ADCIRCA (TADALAFIL) | 80 of 190 | 360 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
16 PROAIR HFA (ALBUTEROL SULFATE) | 450 of 790 | 240 prescriptions Less than 1% of all prescriptions | | 110 patients 4% of all patients | < 11 | |
17 FUROSEMIDE | 310 of 590 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 POTASSIUM CHLORIDE | 160 of 270 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 TEMAZEPAM | 70 of 130 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 CLONAZEPAM | 130 of 210 | 240 prescriptions Less than 1% of all prescriptions | 240 | < 11 | < 11 | |
21 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 400 of 720 | 260 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 SILDENAFIL (SILDENAFIL CITRATE) | 80 of 260 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
23 ALPRAZOLAM | 200 of 280 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 DALIRESP (ROFLUMILAST) | 340 of 510 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
25 DIAZEPAM | 40 of 70 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 DEXTROAMPHETAMINE-AMPHETAMINE (DEXTROAMPHETAMINE/AMPHETAMINE) | 20 of 40 | 180 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
27 IPRATROPIUM BROMIDE | 180 of 220 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
28 OPSUMIT (MACITENTAN) | 120 of 150 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
29 DYMISTA (AZELASTINE/FLUTICASONE) | 20 of 20 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
30 AZITHROMYCIN | 440 of 800 | 300 prescriptions Less than 1% of all prescriptions | | 220 patients 8% of all patients | < 11 | A |
31 LEVOFLOXACIN | 210 of 480 | 140 prescriptions Less than 1% of all prescriptions | | 120 patients 4% of all patients | < 11 | A |